IBDEI1H6 ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,23862,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23862,1,3,0)
;;=3^Heart Failure,End Stage
;;^UTILITY(U,$J,358.3,23862,1,4,0)
;;=4^I50.84
;;^UTILITY(U,$J,358.3,23862,2)
;;=^5151391
;;^UTILITY(U,$J,358.3,23863,0)
;;=I50.89^^82^1033^11
;;^UTILITY(U,$J,358.3,23863,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23863,1,3,0)
;;=3^Heart Failure,Other
;;^UTILITY(U,$J,358.3,23863,1,4,0)
;;=4^I50.89
;;^UTILITY(U,$J,358.3,23863,2)
;;=^5151392
;;^UTILITY(U,$J,358.3,23864,0)
;;=E03.9^^82^1034^21
;;^UTILITY(U,$J,358.3,23864,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23864,1,3,0)
;;=3^Hypothyroidism,Unspec
;;^UTILITY(U,$J,358.3,23864,1,4,0)
;;=4^E03.9
;;^UTILITY(U,$J,358.3,23864,2)
;;=^5002476
;;^UTILITY(U,$J,358.3,23865,0)
;;=E11.9^^82^1034^13
;;^UTILITY(U,$J,358.3,23865,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23865,1,3,0)
;;=3^DM Type 2 w/o Complications
;;^UTILITY(U,$J,358.3,23865,1,4,0)
;;=4^E11.9
;;^UTILITY(U,$J,358.3,23865,2)
;;=^5002666
;;^UTILITY(U,$J,358.3,23866,0)
;;=E10.9^^82^1034^7
;;^UTILITY(U,$J,358.3,23866,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23866,1,3,0)
;;=3^DM Type 1 w/o Complications
;;^UTILITY(U,$J,358.3,23866,1,4,0)
;;=4^E10.9
;;^UTILITY(U,$J,358.3,23866,2)
;;=^5002626
;;^UTILITY(U,$J,358.3,23867,0)
;;=E11.65^^82^1034^9
;;^UTILITY(U,$J,358.3,23867,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23867,1,3,0)
;;=3^DM Type 2 w/ Hyperglycemia
;;^UTILITY(U,$J,358.3,23867,1,4,0)
;;=4^E11.65
;;^UTILITY(U,$J,358.3,23867,2)
;;=^5002663
;;^UTILITY(U,$J,358.3,23868,0)
;;=E10.65^^82^1034^5
;;^UTILITY(U,$J,358.3,23868,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23868,1,3,0)
;;=3^DM Type 1 w/ Hyperglycemia
;;^UTILITY(U,$J,358.3,23868,1,4,0)
;;=4^E10.65
;;^UTILITY(U,$J,358.3,23868,2)
;;=^5002623
;;^UTILITY(U,$J,358.3,23869,0)
;;=E11.8^^82^1034^8
;;^UTILITY(U,$J,358.3,23869,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23869,1,3,0)
;;=3^DM Type 2 w/ Complications,Unspec
;;^UTILITY(U,$J,358.3,23869,1,4,0)
;;=4^E11.8
;;^UTILITY(U,$J,358.3,23869,2)
;;=^5002665
;;^UTILITY(U,$J,358.3,23870,0)
;;=E10.8^^82^1034^4
;;^UTILITY(U,$J,358.3,23870,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23870,1,3,0)
;;=3^DM Type 1 w/ Complications,Unspec
;;^UTILITY(U,$J,358.3,23870,1,4,0)
;;=4^E10.8
;;^UTILITY(U,$J,358.3,23870,2)
;;=^5002625
;;^UTILITY(U,$J,358.3,23871,0)
;;=E53.8^^82^1034^31
;;^UTILITY(U,$J,358.3,23871,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23871,1,3,0)
;;=3^Vitamin B Group Deficiency
;;^UTILITY(U,$J,358.3,23871,1,4,0)
;;=4^E53.8
;;^UTILITY(U,$J,358.3,23871,2)
;;=^5002797
;;^UTILITY(U,$J,358.3,23872,0)
;;=E78.5^^82^1034^20
;;^UTILITY(U,$J,358.3,23872,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23872,1,3,0)
;;=3^Hyperlipidemia,Unspec
;;^UTILITY(U,$J,358.3,23872,1,4,0)
;;=4^E78.5
;;^UTILITY(U,$J,358.3,23872,2)
;;=^5002969
;;^UTILITY(U,$J,358.3,23873,0)
;;=E66.9^^82^1034^28
;;^UTILITY(U,$J,358.3,23873,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23873,1,3,0)
;;=3^Obesity,Unspec
;;^UTILITY(U,$J,358.3,23873,1,4,0)
;;=4^E66.9
;;^UTILITY(U,$J,358.3,23873,2)
;;=^5002832
;;^UTILITY(U,$J,358.3,23874,0)
;;=E66.01^^82^1034^26
;;^UTILITY(U,$J,358.3,23874,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23874,1,3,0)
;;=3^Morbid Obesity d/t Excess Calories
;;^UTILITY(U,$J,358.3,23874,1,4,0)
;;=4^E66.01
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1H6 3763 printed Apr 09, 2024@21:01:26 Page 2
IBDEI1H6 ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,23862,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,23862,1,3,0)
+4 ;;=3^Heart Failure,End Stage
+5 ;;^UTILITY(U,$J,358.3,23862,1,4,0)
+6 ;;=4^I50.84
+7 ;;^UTILITY(U,$J,358.3,23862,2)
+8 ;;=^5151391
+9 ;;^UTILITY(U,$J,358.3,23863,0)
+10 ;;=I50.89^^82^1033^11
+11 ;;^UTILITY(U,$J,358.3,23863,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,23863,1,3,0)
+14 ;;=3^Heart Failure,Other
+15 ;;^UTILITY(U,$J,358.3,23863,1,4,0)
+16 ;;=4^I50.89
+17 ;;^UTILITY(U,$J,358.3,23863,2)
+18 ;;=^5151392
+19 ;;^UTILITY(U,$J,358.3,23864,0)
+20 ;;=E03.9^^82^1034^21
+21 ;;^UTILITY(U,$J,358.3,23864,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,23864,1,3,0)
+24 ;;=3^Hypothyroidism,Unspec
+25 ;;^UTILITY(U,$J,358.3,23864,1,4,0)
+26 ;;=4^E03.9
+27 ;;^UTILITY(U,$J,358.3,23864,2)
+28 ;;=^5002476
+29 ;;^UTILITY(U,$J,358.3,23865,0)
+30 ;;=E11.9^^82^1034^13
+31 ;;^UTILITY(U,$J,358.3,23865,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,23865,1,3,0)
+34 ;;=3^DM Type 2 w/o Complications
+35 ;;^UTILITY(U,$J,358.3,23865,1,4,0)
+36 ;;=4^E11.9
+37 ;;^UTILITY(U,$J,358.3,23865,2)
+38 ;;=^5002666
+39 ;;^UTILITY(U,$J,358.3,23866,0)
+40 ;;=E10.9^^82^1034^7
+41 ;;^UTILITY(U,$J,358.3,23866,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,23866,1,3,0)
+44 ;;=3^DM Type 1 w/o Complications
+45 ;;^UTILITY(U,$J,358.3,23866,1,4,0)
+46 ;;=4^E10.9
+47 ;;^UTILITY(U,$J,358.3,23866,2)
+48 ;;=^5002626
+49 ;;^UTILITY(U,$J,358.3,23867,0)
+50 ;;=E11.65^^82^1034^9
+51 ;;^UTILITY(U,$J,358.3,23867,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,23867,1,3,0)
+54 ;;=3^DM Type 2 w/ Hyperglycemia
+55 ;;^UTILITY(U,$J,358.3,23867,1,4,0)
+56 ;;=4^E11.65
+57 ;;^UTILITY(U,$J,358.3,23867,2)
+58 ;;=^5002663
+59 ;;^UTILITY(U,$J,358.3,23868,0)
+60 ;;=E10.65^^82^1034^5
+61 ;;^UTILITY(U,$J,358.3,23868,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,23868,1,3,0)
+64 ;;=3^DM Type 1 w/ Hyperglycemia
+65 ;;^UTILITY(U,$J,358.3,23868,1,4,0)
+66 ;;=4^E10.65
+67 ;;^UTILITY(U,$J,358.3,23868,2)
+68 ;;=^5002623
+69 ;;^UTILITY(U,$J,358.3,23869,0)
+70 ;;=E11.8^^82^1034^8
+71 ;;^UTILITY(U,$J,358.3,23869,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,23869,1,3,0)
+74 ;;=3^DM Type 2 w/ Complications,Unspec
+75 ;;^UTILITY(U,$J,358.3,23869,1,4,0)
+76 ;;=4^E11.8
+77 ;;^UTILITY(U,$J,358.3,23869,2)
+78 ;;=^5002665
+79 ;;^UTILITY(U,$J,358.3,23870,0)
+80 ;;=E10.8^^82^1034^4
+81 ;;^UTILITY(U,$J,358.3,23870,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,23870,1,3,0)
+84 ;;=3^DM Type 1 w/ Complications,Unspec
+85 ;;^UTILITY(U,$J,358.3,23870,1,4,0)
+86 ;;=4^E10.8
+87 ;;^UTILITY(U,$J,358.3,23870,2)
+88 ;;=^5002625
+89 ;;^UTILITY(U,$J,358.3,23871,0)
+90 ;;=E53.8^^82^1034^31
+91 ;;^UTILITY(U,$J,358.3,23871,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,23871,1,3,0)
+94 ;;=3^Vitamin B Group Deficiency
+95 ;;^UTILITY(U,$J,358.3,23871,1,4,0)
+96 ;;=4^E53.8
+97 ;;^UTILITY(U,$J,358.3,23871,2)
+98 ;;=^5002797
+99 ;;^UTILITY(U,$J,358.3,23872,0)
+100 ;;=E78.5^^82^1034^20
+101 ;;^UTILITY(U,$J,358.3,23872,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,23872,1,3,0)
+104 ;;=3^Hyperlipidemia,Unspec
+105 ;;^UTILITY(U,$J,358.3,23872,1,4,0)
+106 ;;=4^E78.5
+107 ;;^UTILITY(U,$J,358.3,23872,2)
+108 ;;=^5002969
+109 ;;^UTILITY(U,$J,358.3,23873,0)
+110 ;;=E66.9^^82^1034^28
+111 ;;^UTILITY(U,$J,358.3,23873,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,23873,1,3,0)
+114 ;;=3^Obesity,Unspec
+115 ;;^UTILITY(U,$J,358.3,23873,1,4,0)
+116 ;;=4^E66.9
+117 ;;^UTILITY(U,$J,358.3,23873,2)
+118 ;;=^5002832
+119 ;;^UTILITY(U,$J,358.3,23874,0)
+120 ;;=E66.01^^82^1034^26
+121 ;;^UTILITY(U,$J,358.3,23874,1,0)
+122 ;;=^358.31IA^4^2
+123 ;;^UTILITY(U,$J,358.3,23874,1,3,0)
+124 ;;=3^Morbid Obesity d/t Excess Calories
+125 ;;^UTILITY(U,$J,358.3,23874,1,4,0)
+126 ;;=4^E66.01
